A drug that is available from more than one manufacturer or distributor, often under different brand names. Limits on reimbursement are more likely to be feasible for multisource drugs than drugs available from only a single source. A drug may not be available from more than one source because it is protected by a patent; only one company has obtained FDA marketing approval; or the demand for it is such that only one supplier has entered the market.